Net profit of Medicamen Biotech declined 27.43% to Rs 1.64 crore in the quarter ended June 2025 as against Rs 2.26 crore during the previous quarter ended June 2024. Sales declined 7.30% to Rs 38.45 crore in the quarter ended June 2025 as against Rs 41.48 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 38.45 | 41.48 | -7 |
| OPM % | 10.48 | 11.72 | - |
| PBDT | 3.94 | 4.76 | -17 |
| PBT | 2.17 | 3.02 | -28 |
| NP | 1.64 | 2.26 | -27 |